eyesON | Phase II Vanguards
Phase II Vanguards data visualization tool provides oversight of groundbreaking investigational new drugs and under-the-radar institutions developing them.
Jul
2023
Oct
2025
CASE STUDY | Phase III Oncology: Targeted Risk-Based QA
For oncology study teams: see how ADAMAS applied Cyntegrity’s risk signals to focus QA in a global Phase III trial, supporting earlier actions and inspection readiness.
Oct
2025
MHRA 2025: New Guidance for Medical Device Investigations
The MHRA’s latest guidance clarifies how medical device investigations are managed across Great Britain and Northern Ireland. Cyntegrity helps manufacturers stay inspection-ready with AI-enhanced RBQM tools that strengthen documentation, risk control, and overall data quality from design through post-market follow-up.
Sep
2025
World Heart Day 2025: Smarter Heart Trials
On World Heart Day 2025, Cyntegrity highlights the importance of safer, smarter cardiovascular clinical trials. Using the Heart Failure RACT and Risk-Based Quality Management, we help identify patient risks early, improve trial design, and ensure data quality keeping patient safety at the heart of every study.
Sep
2025
Clinical Trials and Patient Safety
Every 17 September, World Patient Safety Day reminds our industry that safety is not just an outcome, it’s a discipline. In clinical research, safety begins long before first-patient-in and continues with every data point captured, every deviation resolved, and every monitoring decision made.
Sep
2025
FDA Finalizes ICH E6(R3) Guidance, But U.S. Timeline Still Unclear
The FDA has published the finalized ICH E6(R3) Good Clinical Practice guidance. Unlike Europe’s July 23 deadline, the U.S. implementation date is still to be announced. This creates uncertainty for sponsors and CROs operating across regions, highlighting the importance of early preparation and alignment with global standards.
Aug
2025
Law of Attraction & Power of Imagination
In our community learning session with Giray Görbil (Clinical Marketing Coordinator at Cyntegrity), we explored the fascinating connection between the "Law of Attraction and the Power of Imagination". These two concepts, when combined, can unlock new ways of thinking, creating, and shaping our personal [...]
Jul
2025
Selling Across Cultures: Pitching to Global Clients
In today’s global market, success isn’t just about offering a great product or service it’s about connecting with people from different cultures in a meaningful way. The latest Community Learning Session with Julien Goncalves (Head of Growth at Cyntegrity) shared valuable insights during his [...]
Jul
2025
3rd Annual ACDM Symposium 2025
Join Cyntegrity at the ACDM RBQM Symposium 2025 in Amsterdam! Don’t miss Johann Proeve’s expert talk on ICH E6(R3), E8(R1), and CDM evolution.
Jun
2025
SCOPE Europe Summit 2025, Barcelona
Join Cyntegrity at SCOPE 2025 Barcelona, Booth #4, and explore how AI-powered RBQM cuts review cycles by 30% and boosts inspection readiness.
Jun
2025
DIA 2025 Posters: Rare-Disease & CRF-RBQM Wins
Download our DIA 2025 posters and see how upfront RBQM—applied to rare-disease trials and joint CRF design—sharpens data quality, elevates patient safety, and keeps studies ICH E6(R3)-ready.